Syndax Pharmaceuticals News

Syndax Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-STATE STREET CORPORATION :(4.4%)

Oct 18 11:54 ET

Syndax Pharmaceuticals | 8-K: Syndax Reports Second Quarter 2024 Financial Results and Provides Clinical and Business Update

Aug 1 16:09 ET

Syndax Pharmaceuticals | 10-Q: Q2 2024 Earnings Report

Aug 1 16:06 ET

Syndax Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Goldan Keith A.

Jun 17 09:30 ET

Syndax Pharmaceuticals | 3: Initial statement of beneficial ownership of securities-Director Rizo Aleksandra

May 16 16:08 ET

Syndax Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Rizo Aleksandra

May 16 16:08 ET

Syndax Pharmaceuticals | 8-K: Current report

May 15 16:23 ET

Syndax Pharmaceuticals | 10-Q: Q1 2024 Earnings Report

May 8 07:08 ET

Syndax Pharmaceuticals | 8-K: Syndax Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Clinical and Business Update

May 8 07:08 ET

Syndax Pharmaceuticals | ARS: Annual Report to Security Holders

Apr 2 16:37 ET

Syndax Pharmaceuticals | DEF 14A: Definitive information statements

Apr 2 16:18 ET

Syndax Pharmaceuticals | DEFA14A: Others

Apr 2 16:05 ET

Syndax Pharmaceuticals | 8-K: Current report

Mar 18 07:14 ET

Syndax Pharmaceuticals | 10-K: FY2023 Annual Report

Feb 27 22:50 ET

Syndax Pharmaceuticals | S-3ASR: Automatic shelf registration statement of securities of well-known seasoned issuers

Feb 27 17:32 ET

Syndax Pharmaceuticals | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Feb 27 17:28 ET

Syndax Pharmaceuticals | 8-K: Syndax Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Clinical and Business Update

Feb 27 16:09 ET

Syndax Pharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals-Kynam Capital Management, LP(6.67%),Kynam Capital Management GP, LLC(6.67%), etc.

Feb 14 12:53 ET

Syndax Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Point72 Asset Management, L.P.(3.3%),Point72 Capital Advisors, Inc.(3.3%), etc.

Feb 14 07:06 ET

Syndax Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Avidity Partners Management LP(4.7%),Avidity Partners Management (GP) LLC(4.7%), etc.

Feb 13 21:46 ET